GlaxoSmithKline
GSK
#216
Rank
S$124.74 B
Marketcap
S$61.58
Share price
-2.06%
Change (1 day)
31.91%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: S$124.74 Billion

As of December 2025 GlaxoSmithKline has a market cap of S$124.74 Billion. This makes GlaxoSmithKline the world's 216th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025S$124.74 B31.99%
2024S$94.51 B-6.15%
2023S$100.70 B4.43%
2022S$96.43 B-34.62%
2021S$147.50 B21.5%
2020S$121.39 B-22.63%
2019S$156.90 B22.27%
2018S$128.33 B8.89%
2017S$117.85 B-13.57%
2016S$136.36 B-2.68%
2015S$140.11 B1.8%
2014S$137.64 B-15.79%
2013S$163.45 B26.37%
2012S$129.34 B-13.3%
2011S$149.18 B13.66%
2010S$131.25 B-14.74%
2009S$153.94 B11.37%
2008S$138.23 B-30.78%
2007S$199.71 B-14.22%
2006S$232.82 B-5.11%
2005S$245.36 B6.9%
2004S$229.52 B2.59%
2003S$223.73 B14.28%
2002S$195.78 B-31.22%
2001S$284.65 B-6.77%
2000S$305.31 B80.28%
1999S$169.35 B-18.58%
1998S$208.01 B44.18%
1997S$144.27 B83.16%
1996S$78.77 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of GlaxoSmithKline was reported to be:

S$128.25 Billion
by Nasdaq info icon info icon
S$126.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
S$362.19 B 190.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$187.53 B 50.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$315.02 B 152.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$326.46 B 161.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$152.13 B 21.96%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
S$42.69 B-65.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
S$1.66 B-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA